Romano Brothers AND Company lessened its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 0.9% in the first quarter, according to its most recent filing with the SEC. The fund owned 14,979 shares of the company’s stock after selling 137 shares during the period. Romano Brothers AND Company’s holdings in Clorox were worth $2,293,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Point72 Asset Management L.P. acquired a new position in shares of Clorox in the fourth quarter worth $144,844,000. Norges Bank acquired a new position in shares of Clorox in the fourth quarter worth $128,382,000. Parsifal Capital Management LP acquired a new position in shares of Clorox in the fourth quarter worth $128,245,000. Confluence Investment Management LLC acquired a new position in shares of Clorox in the first quarter worth $135,630,000. Finally, International Assets Investment Management LLC increased its stake in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Clorox Price Performance
Shares of Clorox stock traded down $0.13 during midday trading on Friday, reaching $136.47. The company had a trading volume of 1,667,373 shares, compared to its average volume of 1,254,727. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $16.95 billion, a price-to-earnings ratio of 70.71, a price-to-earnings-growth ratio of 2.19 and a beta of 0.39. The stock has a fifty day simple moving average of $136.95 and a 200 day simple moving average of $143.80. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14.
Analyst Ratings Changes
A number of brokerages recently issued reports on CLX. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a report on Wednesday, April 17th. Barclays decreased their price objective on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Wells Fargo & Company decreased their price objective on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Finally, The Goldman Sachs Group assumed coverage on shares of Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price target for the company. Five research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $145.33.
Read Our Latest Research Report on CLX
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- 3 Warren Buffett Stocks to Buy Now
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What is MarketRank™? How to Use it
- MarketBeat Week in Review – 6/24 – 6/28
- NYSE Stocks Give Investors a Variety of Quality Options
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.